U.S. Electric Utilities Stock News

Wondering if Opera's recent share price puts it in the bargain bin or the overhyped aisle? This article breaks down what the numbers say about value. At a last close of US$17.23, Opera's share price comes with recent returns of 0.6% over 7 days, 25.6% over 30 days, 21.1% year to date, 16.3% over 1 year, 67.0% over 3 years, and 105.9% over 5 years. These moves sit against a backdrop of ongoing interest in Opera as a software name, with headlines frequently focusing on its role as a browser...

Wondering whether Palvella Therapeutics at around US$123.59 still offers value, or if most of the easy gains are already behind it? This article walks through what the current price could mean for you. The stock has seen a 23.2% return year to date and a 386.8% return over the last year, alongside shorter term moves of a 2.7% return over 30 days and a 4.9% decline over the past week. Recent attention on Palvella Therapeutics has centered on how the market is reassessing smaller biotech names...

If you are wondering whether Wintrust Financial at US$147.91 still offers value or is starting to look stretched, the recent share price and fundamentals give you some clear clues to work with. The stock has held up over the last week with a 0.2% decline. The 30 day return sits at 8.0% and the 1 year return at 35.6%, with longer term returns of 128.2% over 3 years and 108.7% over 5 years. Recent coverage has focused on Wintrust Financial as part of broader discussions around US regional...

FDA extends Priority Review for Savara’s molgramostim BLA in autoimmune PAP by three months following a major amendment. Regulator cites no new safety, efficacy, or manufacturing concerns in connection with the extension. Extension reflects ongoing review activity for Savara’s lead product candidate, ticker NasdaqGS:SVRA. Savara, listed on NasdaqGS:SVRA, focuses on therapies for rare respiratory diseases, with molgramostim as its most advanced program targeting autoimmune pulmonary alveolar...

Instacart, listed as NasdaqGS:CART under Maplebear, has announced the acquisition of Instaleap. Instaleap operates a fulfillment and enablement platform across roughly 30 countries outside North America. The deal is intended to expand Instacart's enterprise services across Europe, Latin America, and the Middle East. Instacart's parent company Maplebear, trading at $42.17, is adding Instaleap to widen its international reach beyond its core North American base. The move comes after a 15.9%...

Activist investor Land & Buildings has criticized Welltower's new executive compensation plan, describing it as unusually aggressive. The investor argues the structure could work against shareholder interests and weaken alignment between management and owners. The dispute focuses on governance and incentives at NYSE:WELL, rather than short term operating performance. For investors watching NYSE:WELL, this governance debate arrives with the shares at $208.75 and with very large longer term...

Maze Therapeutics (NasdaqGM:MAZE) completed a sizable underwritten public offering of common stock and pre funded warrants. The deal drew significant participation from both new and existing institutional investors. Proceeds are earmarked to advance Maze Therapeutics' research and development programs focused on serious diseases. Maze Therapeutics, trading at a recent share price of $25.81, has experienced sharp share price swings, with a 7 day return of an 8.1% decline and a 30 day return...

If you are wondering whether IAC is attractively priced or if the recent buzz is already reflected in the share price, this article walks through the key signals that matter for valuation focused investors. IAC shares last closed at US$44.48, with returns of 0.3% over 7 days, 11.5% over 30 days, 13.9% year to date and 25.1% over 1 year, compared with a much weaker 3 year return of 4.3% and a 5 year return showing a 68.0% decline. Recent headlines around IAC have kept attention on how the...

Wondering whether Korn Ferry at around US$65.80 still offers value or if the easy gains are behind it? This article walks through what the current price might be implying. The stock has returned 0.1% over the last 7 days and 4.4% over the past month, with a 9.5% return over 1 year, set against a small year to date decline of 0.9% and a 47.0% return over 3 years. These moves sit against a backdrop where investors are paying closer attention to established business models and balance sheet...

Rogers (NYSE:ROG) reports that its turnaround plan is driving structural cost reductions and operational improvements. The company highlights better operating efficiency and traction in industrial, ADAS, and renewable energy markets. These updates follow a period of sales and profitability pressure and point to a shift in business momentum. Rogers, a specialty materials producer, is closely tied to demand trends in sectors such as industrial applications, advanced driver assistance systems,...

In the past week, Catalyst Pharmaceuticals reported stronger traction for its rare-disease drugs Firdapse and Agamree, alongside expectations for modest quarterly revenue growth supported by a solid balance sheet. This combination of growing product momentum and anticipation around upcoming earnings has drawn fresh attention to how Catalyst’s rare-disease portfolio may evolve in the global market. Now we’ll examine how this stronger Firdapse and Agamree momentum could reshape Catalyst...

Investors may be wondering whether Old Second Bancorp at around US$20 still offers value, or if most of the upside has already been priced in. The stock has recently seen an 8.8% decline over the last 7 days, set against a 2.0% return over 30 days, 2.7% year to date and 29.8% over 1 year. Recent coverage has focused on Old Second Bancorp in the context of broader bank sector sentiment and how investors are reassessing risk and return across regional financials. This background helps frame...

Valmont Industries (NYSE:VMI) plans to host an Investor Day on June 16, 2026. Senior leadership is expected to share long term strategy updates and key value drivers. The event will cover the company’s infrastructure and agricultural segments for in person and webcast audiences. Valmont Industries focuses on infrastructure and agricultural solutions, including utility structures and agrotechnology. Investor Day gives you a chance to hear directly from management about how these businesses...

Oceaneering International (NYSE:OII) reported one of its strongest quarterly order intakes since 2020, with around US$1b of orders in Q1. The company introduced Momentum, a next generation electric work class ROV, expanding its subsea robotics offering. These updates add new detail on Oceaneering's order backlog and technology roadmap beyond recent earnings headlines. Oceaneering International, a long established provider of subsea services and robotics for energy and industrial customers,...

If you are wondering whether Ethos Technologies at around US$16.77 still offers value or is already pricing in a lot of optimism, you are not alone. The stock has moved 3.5% over the last 7 days and 66.0% over the last 30 days, while the year to date return is around a 0.5% decline. This raises clear questions about what is now baked into the price. Recent coverage has focused on Ethos Technologies as part of a broader look at insurance names, highlighting how sentiment can shift quickly...

Wondering whether Pebblebrook Hotel Trust at around US$13.96 still offers value, or if the easy upside is gone? A useful starting point is understanding how its price stacks up against its fundamentals. The stock has delivered a 52.9% return over the last year, with gains of 20.9% year to date and 9.4% over the last month. However, the 3 year and 5 year returns of a 1.0% decline and a 40.7% decline show a very different longer term picture. Recent coverage has focused on how hotel and resort...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

PennyMac Financial Services and PennyMac Mortgage Investment Trust recently launched the “Welcome Home: Athlete Mortgage Program,” extending specialized mortgage guidance, exclusive benefits, and educational resources to the wider Team USA athlete community in partnership with the U.S. Olympic & Paralympic Committee. The initiative highlights Pennymac’s effort to cultivate a differentiated client base by tailoring lending support to the unique financial profiles of elite athletes. Next,...

There's been a notable change in appetite for Calix, Inc. ( NYSE:CALX ) shares in the week since its quarterly report...

Antero Midstream Corporation ( NYSE:AM ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Atomera Incorporated recently announced it has expanded its long-running collaboration with Synopsys to develop gallium nitride (GaN) device modeling workflows for radio frequency and power semiconductor applications using Synopsys’ Sentaurus TCAD and Atomera’s MSTcad toolset. This move extends Atomera’s MST modeling capabilities into GaN, potentially deepening its role in high-value RF and power markets by integrating more tightly into Synopsys’ widely used design ecosystem. We’ll now...

Evolv Technologies Holdings, Inc. recently announced multi-year subscription agreements and marketing partnerships with the University of Washington’s athletic department and Crypto.com Arena, expanding deployments of its Evolv Express Gen2 and eXpedite AI-based screening systems across major college and professional sports venues. These high-traffic stadium and arena wins highlight growing adoption of Evolv’s subscription-based security platforms in sports and entertainment, reinforcing its...

Recent share performance and business snapshot Lucky Strike Entertainment (LUCK) has drawn attention after a recent pullback, with the share price closing at US$7.24 as investors reassess the business following its rebrand from Bowlero Corp. The company runs a portfolio of bowling centers and entertainment venues across North America, including AMF, Bowl America, Lucky Strike, Bowlero, Octane Raceway, several water parks, and Boomers Parks. It has reported revenue of US$1,240.203 million and...